These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1227 related articles for article (PubMed ID: 19713601)
1. New real-time image fusion technique for characterization of tumor vascularisation and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. Jung EM; Schreyer AG; Schacherer D; Menzel C; Farkas S; Loss M; Feuerbach S; Zorger N; Fellner C Clin Hemorheol Microcirc; 2009; 43(1-2):57-69. PubMed ID: 19713601 [TBL] [Abstract][Full Text] [Related]
2. Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results. Ross CJ; Rennert J; Schacherer D; Girlich C; Hoffstetter P; Heiss P; Jung W; Feuerbach S; Zorger N; Jung EM Clin Hemorheol Microcirc; 2010; 46(2-3):101-15. PubMed ID: 21135486 [TBL] [Abstract][Full Text] [Related]
3. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors. Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679 [TBL] [Abstract][Full Text] [Related]
4. Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results. Jung EM; Ross CJ; Rennert J; Scherer MN; Farkas S; von Breitenbuch P; Schnitzbauer AA; Piso P; Lamby P; Menzel C; Schreyer AG; Feuerbach S; Schlitt HJ; Loss M Clin Hemorheol Microcirc; 2010; 46(2-3):89-99. PubMed ID: 21135485 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of treatment response after chemoembolisation (TACE) in hepatocellular carcinoma using real time image fusion of contrast-enhanced ultrasound (CEUS) and computed tomography (CT)--preliminary results. Wobser H; Wiest R; Salzberger B; Wohlgemuth WA; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2014; 57(2):191-201. PubMed ID: 24577382 [TBL] [Abstract][Full Text] [Related]
6. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions - prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreiländertreffen 2008, Davos. Seitz K; Strobel D; Bernatik T; Blank W; Friedrich-Rust M; Herbay Av; Dietrich CF; Strunk H; Kratzer W; Schuler A Ultraschall Med; 2009 Aug; 30(4):383-9. PubMed ID: 19688670 [TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area. Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332 [TBL] [Abstract][Full Text] [Related]
8. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669 [TBL] [Abstract][Full Text] [Related]
9. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound. Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287 [TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study. Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Liver Tumors Using Preoperative and Intraoperative Contrast-Enhanced Ultrasound (CEUS/IOCEUS) by Radiologists in Comparison to Magnetic Resonance Imaging and Histopathology. Huf S; Platz Batista da Silva N; Wiesinger I; Hornung M; Scherer MN; Lang S; Stroszczynski C; Fischer T; Jung EM Rofo; 2017 May; 189(5):431-440. PubMed ID: 28449169 [No Abstract] [Full Text] [Related]
12. [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors]. Jung EM; Clevert DA; Rupp N Rofo; 2003 Oct; 175(10):1403-12. PubMed ID: 14556110 [TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients. Seitz K; Bernatik T; Strobel D; Blank W; Friedrich-Rust M; Strunk H; Greis C; Kratzer W; Schuler A Ultraschall Med; 2010 Oct; 31(5):492-9. PubMed ID: 20652854 [TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound improves real-time imaging of ablation region during radiofrequency ablation: preliminary results. Wiggermann P; Zuber-Jerger I; Zausig Y; Loss M; Scherer MN; Schreyer AG; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2011; 49(1-4):43-54. PubMed ID: 22214677 [TBL] [Abstract][Full Text] [Related]
16. [Ultrasound guided ablation therapy of hepatic colorectal metastases: initial experience of real time virtual sonography navigation system]. Yuan CH; Xiu DR; Ge HY; Tan S; Wang HY; Zhang L; Zhang TL Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec; 45(6):956-9. PubMed ID: 24343081 [TBL] [Abstract][Full Text] [Related]
17. Comparison of computed tomography (CT) and contrast-enhanced ultrasound (CEUS) for the quantitative evaluation of an ablation defect following radiofrequency ablation of malignant liver lesions. Bruenn K; Beyer L; Haimerl M; Pregler B; Stroszczynski C; Jung EM; Wiggermann P Clin Hemorheol Microcirc; 2017; 67(3-4):445-451. PubMed ID: 28885212 [TBL] [Abstract][Full Text] [Related]
18. Intraoperative high resolution linear contrast enhanced ultrasound (IOUS) for detection of microvascularization of malignant liver lesions before surgery or radiofrequeny ablation. Loss M; Schneider J; Uller W; Wiggermann P; Scherer MN; Jung W; Schlitt HJ; Stroszczynski C; Jung EM Clin Hemorheol Microcirc; 2012; 50(1-2):65-77. PubMed ID: 22538536 [TBL] [Abstract][Full Text] [Related]
19. Unclear focal liver lesions in contrast-enhanced ultrasonography--lessons to be learned from the DEGUM multicenter study for the characterization of liver tumors. Bernatik T; Seitz K; Blank W; Schuler A; Dietrich CF; Strobel D Ultraschall Med; 2010 Dec; 31(6):577-81. PubMed ID: 20740399 [TBL] [Abstract][Full Text] [Related]
20. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison). Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]